ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0787

Efficacy of Intra-Articular Hyaluronic Acid Injection for Nonsurgical Management of Carpometacarpal Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Mohamed Abdelsalam1, omnia Samy2 and Asmaa al-Najjar3, 1Rheumatology, Rehabilitation and Physical medicine department - faculty of medicine -Misr University for science and technology, 6th of October, Al Jizah, Egypt, 2Faculty of medicine - Zagazig university, Al Zagazig, Egypt, 3Faculty of medicine - Al-Azhar university in Gaza, Gaza, Palestinian Territories

Meeting: ACR Convergence 2024

Keywords: grip strength, Hyaluronan, meta-analysis, Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Abstracts: Osteoarthritis – Clinical Trials

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Carpometacarpal osteoarthritis (CMC OA) is a painful condition affecting 21% of hand OA patients. Various treatment modalities have been explored to reduce pain and improve function, including intra-articular injections of hyaluronic acid (HA). However, the effectiveness of HA in managing CMC OA remains a topic of debate.

Methods: We conducted a systematic search across multiple databases, including PubMed, Cochrane Library, Web of Science, and Scopus from inception till February 1st, 2024. We included randomized clinical trials evaluating the efficacy of HA in CMC OA (Figure 1). The main outcome was pain at rest measured by visual analogue scale (VAS). We stratified the outcome into short-term (After 1 month) and medium-term (After 3 months) follow-up and long-term (after 6 months) follow-up. We used Rayyan for identifying duplicates, title, abstract and full-text  screening and Review Manager (RevMan) software V.5.3.5 for data analysis.

Results: This systematic review and meta-analysis incorporates data from nine studies, of which seven were included in the main outcome analysis, encompassing a total of 1.070 patients diagnosed with CMC osteoarthritis. The primary objective was to evaluate the efficacy of HA treatment across multiple outcome measures. The VAS for pain relief served as the primary endpoint, demonstrating a significant improvement with HA treatment in short-term (standardized mean difference [SMD] = -0.32, 95% confidence interval [CI]: [-0.52, -0.12]). and medium-term (SMD = -0.56, 95% CI: [-0.81, -0.31]) follow-up and long-term (SMD = -0.29, 95% CI: [-0.54, -0.04]) follow-up than the control groups (figure 2). However, for grip strength, the analysis did not reveal a statistically significant difference (SMD = 0.18, 95% CI: -0.17 to 0.52). Similarly, the tip pinch strength indicated no significant impact of HA treatment (SMD = -0.23, 95% CI: -0.58 to 0.11) (Figure 3). 

Conclusion: Intra-articular HA injections provide pain relief in CMC OA, as evidenced by improvements in VAS scores. However, grip strength and tip pinch strength did not show significant differences. Further research and larger randomized controlled trials are warranted to validate these findings.

Supporting image 1

Figure (1) PRISMA Flow Chart Illustrating Search Strategy and Selection of Included Studies

Supporting image 2

Figure (2) Forest plots on outcome pain at rest measured using the visual analog scale (VAS) at short-term (After 1 month) and medium-term ( After 3 months) follow-up and long-term (after 6 months) follow-up. Comparison of intra-articular hyaluronic acid injection vs other interventions in patients with carpometacarpal osteoarthritis. Studies with short-term follow-up include Sabaah 2020, Stahl 2005, Monfort 2014,Tenti 2017, Mandl 2017, and Bahadir 2009. Studies with medium-term follow-up include Sabaah 2020, Stahl 2005, Monfort 2014,Tenti 2017, and loppolo 2018. Studies with long-term follow-up include Stahl 2005, Monfort 2014,Tenti 2017, and loppolo 2018. *The forest plot on the right show there was significant difference in pain at rest at short-term, medium-term follow-up and long-term follow-up but with high heterogeneity among the studies. *The forest plot on the left show there was insignificant difference in pain at rest at short-term follow-up, medium-term follow-up and long-term follow-up only and reduced heterogeneity to 0 when studies comparing HA to non-injectable interventions (loppolo 2018) or outlier results (Tenti 2017) were excluded from the analysis. CI; confidence interval, df; degrees of freedom, IV; inverse variance, SD; standard deviation

Supporting image 3

Figure (3) (a) Forest plot of grip strength. Comparison of intra-articular hyaluronic acid injection vs other interventions in patients with carpometacarpal osteoarthritis. Studies included were loppolo 2018, Bahadir 2009 and Stahl 2005. There was no significant difference in grip
(b) Forest plot of tip pinch strength. Comparison of intra-articular hyaluronic acid injection vs other interventions in patients with carpometacarpal osteoarthritis. Studies included were loppolo 2018, Bahadir 2009 and Stahl 2005. There was no significant difference in tip pinch strength. CI; confidence interval, df; degrees of freedom, IV; inverse variance, SD; standard deviation.


Disclosures: M. Abdelsalam: None; o. Samy: None; A. al-Najjar: None.

To cite this abstract in AMA style:

Abdelsalam M, Samy o, al-Najjar A. Efficacy of Intra-Articular Hyaluronic Acid Injection for Nonsurgical Management of Carpometacarpal Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Clinical Trials [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/efficacy-of-intra-articular-hyaluronic-acid-injection-for-nonsurgical-management-of-carpometacarpal-osteoarthritis-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/efficacy-of-intra-articular-hyaluronic-acid-injection-for-nonsurgical-management-of-carpometacarpal-osteoarthritis-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology